Literature DB >> 14649973

Effect of antifungal drugs on pathogenic Naegleria spp isolated from natural water sources.

Supathra Tiewcharoen1, Virach Junnu, Surasak Suvoutho.   

Abstract

UNLABELLED: Five of 16 strains of pathogenic Naegleria spp isolated from 350 natural water sources in Taling Chan District, Bangkok had similar molecular weights and zymogram patterns to those of Naegleria fowleri CDCVO 3081 and Thai strain. The in vitro effects of antifungal drugs (amphotericin B, ketoconazole, fluconazole and itraconazole) were tested at the following concentrations: amphotericin B 0.01-0.55 microg/ml, ketoconazole 0.01-0.3 microg/ml, fluconazole 0.75-3.5 mg/ml and itraconazole 4-12 mg/ml respectively. Aliquots (15,000 cells/ml) of the amoebae were placed in the cells of the microtiter plate and incubated at 37 degrees C. Amoebae from each treatment sample were exposed to one of the four antifungal drugs. Statistical analysis was done by dependent t-test. The sensitivity of the antifungal drugs (MIC50) was as follows: amphotericin B 0.03-0.035 microg/ml ketoconazole 0.05-0.15 microg/ml fluconazole 1.75 mg/ml and itraconazole 8-9 mg/ml respectively (p < 0.005).
CONCLUSION: Amphotericin B and ketoconazole are more active against Naegleria fowleri in vitro. The results of the present study should be used as an in vitro screening test for drugs that have potential amebicidal activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14649973

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

Review 1.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Authors:  Jong-Hyun Kim; Suk-Yul Jung; Yang-Jin Lee; Kyoung-Ju Song; Daeho Kwon; Kyongmin Kim; Sun Park; Kyung-Il Im; Ho-Joon Shin
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

3.  Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.

Authors:  Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-03-11       Impact factor: 5.854

4.  CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).

Authors:  Anjan Debnath; Claudia M Calvet; Gareth Jennings; Wenxu Zhou; Alexander Aksenov; Madeline R Luth; Ruben Abagyan; W David Nes; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2017-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.